Literature DB >> 30175050

Smooth sailing for immunotherapy for unresectable stage III non-small cell lung cancer: the PACIFIC study.

Melin J Khandekar1, Rakesh Jain1,2.   

Abstract

Entities:  

Year:  2018        PMID: 30175050      PMCID: PMC6117158          DOI: 10.21037/tcr.2017.12.17

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN: 2218-676X            Impact factor:   1.241


× No keyword cloud information.
  24 in total

1.  Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer.

Authors:  Alex R Menter; Nikki M Carroll; Lori C Sakoda; Thomas Delate; Mark C Hornbrook; Rakesh K Jain; Lawrence H Kushi; Virginia P Quinn; Debra P Ritzwoller
Journal:  Clin Lung Cancer       Date:  2016-08-20       Impact factor: 4.785

2.  Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure.

Authors:  Vikash P Chauhan; Yves Boucher; Cristina R Ferrone; Sylvie Roberge; John D Martin; Triantafyllos Stylianopoulos; Nabeel Bardeesy; Ronald A DePinho; Timothy P Padera; Lance L Munn; Rakesh K Jain
Journal:  Cancer Cell       Date:  2014-07-14       Impact factor: 31.743

3.  Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.

Authors:  Narek Shaverdian; Aaron E Lisberg; Krikor Bornazyan; Darlene Veruttipong; Jonathan W Goldman; Silvia C Formenti; Edward B Garon; Percy Lee
Journal:  Lancet Oncol       Date:  2017-05-24       Impact factor: 41.316

4.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Authors:  Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Melanie A Leiby; Gregory M Lubiniecki; Yue Shentu; Reshma Rangwala; Julie R Brahmer
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

Review 5.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

6.  Pathology: cancer cells compress intratumour vessels.

Authors:  Timothy P Padera; Brian R Stoll; Jessica B Tooredman; Diane Capen; Emmanuelle di Tomaso; Rakesh K Jain
Journal:  Nature       Date:  2004-02-19       Impact factor: 49.962

7.  Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial.

Authors:  Mark A Socinski; Thomas E Stinchcombe; Dominic T Moore; Scott N Gettinger; Roy H Decker; W Jeffrey Petty; A William Blackstock; Garry Schwartz; Scott Lankford; Amir Khandani; David E Morris
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

8.  The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.

Authors:  Howard L Kaufman; John M Kirkwood; F Stephen Hodi; Sanjiv Agarwala; Thomas Amatruda; Steven D Bines; Joseph I Clark; Brendan Curti; Marc S Ernstoff; Thomas Gajewski; Rene Gonzalez; Laura Jane Hyde; David Lawson; Michael Lotze; Jose Lutzky; Kim Margolin; David F McDermott; Donald Morton; Anna Pavlick; Jon M Richards; William Sharfman; Vernon K Sondak; Jeffrey Sosman; Susan Steel; Ahmad Tarhini; John A Thompson; Jill Titze; Walter Urba; Richard White; Michael B Atkins
Journal:  Nat Rev Clin Oncol       Date:  2013-08-27       Impact factor: 66.675

9.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

10.  Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

Authors:  Scott J Antonia; Augusto Villegas; Davey Daniel; David Vicente; Shuji Murakami; Rina Hui; Takashi Yokoi; Alberto Chiappori; Ki H Lee; Maike de Wit; Byoung C Cho; Maryam Bourhaba; Xavier Quantin; Takaaki Tokito; Tarek Mekhail; David Planchard; Young-Chul Kim; Christos S Karapetis; Sandrine Hiret; Gyula Ostoros; Kaoru Kubota; Jhanelle E Gray; Luis Paz-Ares; Javier de Castro Carpeño; Catherine Wadsworth; Giovanni Melillo; Haiyi Jiang; Yifan Huang; Phillip A Dennis; Mustafa Özgüroğlu
Journal:  N Engl J Med       Date:  2017-09-08       Impact factor: 91.245

View more
  4 in total

Review 1.  Toxicity of tumor immune checkpoint inhibitors-more attention should be paid.

Authors:  Yu Liu; Hao Wang; Juan Deng; Chenglong Sun; Yayi He; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2019-12

2.  Distribution of pathogenic bacteria in lower respiratory tract infection in lung cancer patients after chemotherapy and analysis of integron resistance genes in respiratory tract isolates of uninfected patients.

Authors:  Haiyan Liu; Bin Liu; Fade Zheng; Xiaoxia Chen; Lingyun Ye; Yayi He
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

3.  Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.

Authors:  Pranshu Mohindra; Amit Sawant; Robert J Griffin; Narottam Lamichhane; Erina Vlashi; Meng Xu-Welliver; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-02-22       Impact factor: 2.102

4.  T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer.

Authors:  Keyi Jia; Yayi He; Rafal Dziadziuszko; Sha Zhao; Xiaoshen Zhang; Juan Deng; Hao Wang; Fred R Hirsch; Caicun Zhou; Hui Yu; Liping Zhang
Journal:  Transl Lung Cancer Res       Date:  2019-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.